Business Wire

Mary Kay Inc. Advocates for Women’s Empowerment, Safe and Dignified Work Environments at International Women’s Forum – TIME’S UP UK Virtual Event

Share

On May 21st, Mary Kay Inc., an advocate for global women’s empowerment and entrepreneurship, joined the International Women's Forum (IWF) Virtual Conference, for a session titled “SAFE SETS: An online panel discussion with TIME’S UP UK.”

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200722005187/en/

Carolyn Passey, General Manager, Mary Kay United Kingdom & Ireland (Photo: Mary Kay Inc.)

Carolyn Passey, General Manager, Mary Kay United Kingdom & Ireland (Photo: Mary Kay Inc.)

The live session tackled the ever-present issue for women across the globe: sexual harassment and abuse in the workplace. TIME’S UP UK stressed the critical importance of changing the culture to ensure a safe workplace free from harassment and referred to the work being done to define safety for women in film through intimacy guidelines.

The speakers with TIME’S UP UK included:

  • Dame Heather Rabbatts, TIME’S UP UK Chair, Managing Director of Cove Pictures; Chair of Soho Theatre and non-executive board member for Arts Alliance.
  • Ita O’Brien, the UK’s leading Intimacy Coordinator and founder of Intimacy on Set, her company through which she has been developing best practices regarding intimacy and nudity in film, television and theatre and through which she trains Intimacy Coordinators all over the world.

“TIME’S UP’s efforts will help bring about broader change for women in the workplace – worldwide and across industries,” said Carolyn Passey, General Manager of Mary Kay UK and Ireland. “As one of the world’s leading champions of women’s empowerment, Mary Kay is proud to support, through IWF, women leaders who are standing up to give fellow women a voice, help them embrace their identity and define their own boundaries.”

“What was increasingly apparent throughout the conversation was how #MeToo and TIME’S UP have had a huge and positive influence for changing the way productions work, how they are shifting to better practices in many new ways, and in particular with the new role of the Intimacy Coordinator,” said Dame Heather Rabbatts. “The conversation about safe sets is about how we make the culture shift, one industry after another, until we don’t need to have this conversation ever again.”

“‘Yes’, means yes, ‘no’ means no, and ‘maybe’ means no – we celebrate and embrace the ‘no’,” emphasized Ita O’Brien, when talking of the process during which actors get to voice their comfort level when shooting intimate scenes. The firm founded by O’Brien, Intimacy on Set, has put in place guidelines to provide clear lanes of communication and consent not only between actors, but also everyone else involved in shooting intimate and emotional scenes. “Clear boundaries actually create freedom and help understand what is right for you.”

“This line goes to the heart of the matter, and how we are all learning to express where our boundaries lie, and not being afraid to share them,” concluded Dame Heather Rabbatts. “Having in place some mechanisms to protect yourself is very important, so that we know we can exercise a ‘no’. This should empower us in all the sticky and difficult situations that happen in life, whether personal or professional.”

“It is invigorating to witness the influential work that female thought leaders and advocates have achieved over the past several years for the advancement of women’s safety and security in the workplace. These women, some of the most influential thought leaders in the United Kingdom, are on a mission to champion the next generation of women to become tomorrow’s leaders,” said Marty Wikstrom, Member of IWF U.K. and co-chair of the Cornerstone Conference. “IWF has been advancing women’s leadership and championing equality worldwide since 1974, and Mary Kay has been an advocate of women’s entrepreneurship and leadership since 1963. This session reflects a meeting of the minds, and we are proud to showcase this female-fueled partnership.”

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 56 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at MaryKay.com.

About International Women’s Forum (IWF) and the Leadership Foundation

IWF is an invitation-only membership organization of more than 7,000 diverse and accomplished women from 33 nations on six continents. IWF advances women’s leadership and champions equality worldwide by connecting accomplished women both globally and locally. Members include Fortune 500 executives, government leaders from the local to sovereign level, international nonprofit leaders, and luminaries from the academy, arts and sciences: www.iwforum.org.

About TIME’S UP UK

TIME’S UP is an organisation that insists on safe, fair and dignified work for women of all kinds. In response to the growing TIME’S UP movement in the US, a group of UK-based women: actors, producers, writers and others from the film, TV and theatre industries catalysed a sister initiative in the UK. For maximum impact it is set up under the TIME’S UP brand and aims to amplify and reinforce the message already promoted in the US.

The UK movement seeks to build on key elements of the solidarity letter released by TIME’S UP and the statement by the activists attending the Globes, which emphasised the need to highlight the connections between the harassment revelations in Hollywood and the wider, systematic nature of harassment and violence against women across all industries, contexts and countries with the recognition that this issue is universal. We seek strength in unity and maximum cooperation. The activist statement also flagged the ways in which the TIME’S UP initiative joins an ever-growing collective of organisations, movements and leaders working to end gender-based violence. The UK work stands absolutely in solidarity with existing movements: TIME’S UP UK is also now a recently formed charity, and as a charity we can only continue the work with support and donations. We all appreciate that we are experiencing unprecedented challenges but as TIME’S UP focusses on safety for all women in the workplace, which now includes the home, we hope you will be able to support us: www.timesupuk.org.

About Intimacy on Set

Founded in 2018, Intimacy on Set provides services to TV, film, & theatre when dealing with intimacy, sexual content, and nudity. Its Founder, UK’s leading Intimacy Coordinator, Ita O’Brien, pioneered the role of the Intimacy Coordinator and since 2014 has been developing best practice Intimacy on Set Guidelines, which have been widely adopted in the industry. Championed by the TIME’S UP movement and others, the firm advocates for safe, fair and dignified work for everyone. O’Brien has worked on numerous high profile productions including Normal People (BBC3/Hulu), Sex Education 1&2 (Netflix), Gangs of London (Sky Atlantic), The Great (Hulu) and I May Destroy You (BBC/HBO), and has been widely covered in the national and international media as the leading spokesperson in this space: www.intimacyonset.com/.

Contact information

Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

GPD Companies, Inc. to Acquire Distrupol22.1.2021 16:33:00 EETPress release

GPD Companies, Inc., an affiliate of One Rock Capital Partners, LLC (“One Rock”), today announced that it has entered into a definitive agreement to acquire Distrupol, a subsidiary of Univar Solutions Inc. (NYSE: UNVR) and a leading European distributor of thermoplastics to the polymer processing industry. Terms of the transaction, which is expected to close in the first half of 2021, were not disclosed. Headquartered in Surrey, England, with broad geographic reach across Europe, Distrupol has provided value-added sales and application development of thermoplastic resins for over 50 years. Through its decades-long relationships with world class supply partners, the company offers a robust array of superior performance products and solutions that meet the needs of diverse end users from leading and emerging industries, such as the consumer, medical, automotive, and electrical sectors, among others. Distrupol caters to over 1,300 customers across 13 countries with a portfolio of over 4,0

Schlumberger Announces Fourth-Quarter and Full-Year 2020 Results22.1.2021 14:50:00 EETPress release

Schlumberger Limited (NYSE: SLB) today reported results for the fourth-quarter and full-year 2020. Fourth-Quarter Results (Stated in millions, except per share amounts) Three Months Ended Change Dec. 31, 2020 Sept. 30, 2020 Dec. 31, 2019 Sequential Year-on-year Revenue $5,532 $5,258 $8,228 5% -33% Income (loss) before taxes - GAAP basis $471 $(54) $452 n/m 4% Net income (loss) - GAAP basis $374 $(82) $333 n/m 12% Diluted EPS (loss per share) - GAAP basis $0.27 $(0.06) $0.24 n/m 12% Adjusted EBITDA* $1,112 $1,018 $1,648 9% -33% Adjusted EBITDA margin* 20.1% 19.4% 20.0% 73 bps 6 bps Pretax segment operating income* $654 $575 $1,006 14% -35% Pretax segment operating margin* 11.8% 10.9% 12.2% 90 bps -40 bps Net income, excluding charges & credits* $309 $228 $545 35% -43% Diluted EPS, excluding charges & credits* $0.22 $0.16 $0.39 37% -44% Revenue by Geography International $4,343 $4,210 $5,834 3% -26% North America 1,167 1,034 2,339 13% -50% Other 22 14 55 n/m n/m $5,532 $5,258 $8,228 5% -

JEOL: Release of a New Cold Field Emission Cryo-Electron Microscope CRYO ARM™ 300 II (JEM-3300)22.1.2021 09:00:00 EETPress release

JEOL Ltd. (TOKYO:6951) (President & COO Izumi Oi) announces the release of a new cold field emission cryo-electron microscope (cryo-EM), the CRYO ARM™ 300 II (JEM-3300), to be released in January 2021. This new cryo-EM has been developed based on the concept of "Quick and easy to operate and get high-contrast and high-resolution images". This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005316/en/ Cold Field Emission Cryo-Electron Microscope CRYO ARM(TM) 300 II (JEM-3300) (Photo: Business Wire) Development Background Recent dramatic improvement of resolution in single particle analysis (SPA) using cryo-EM has led to SPA as an essential method for structural analysis of proteins. To address this market, JEOL released the CRYO ARM™ 300 in 2017. Equipped with a cold field emission gun (Cold FEG) for enhanced resolution and a cryo-stage for loading multiple samples, the CRYO ARM™ 300 has continued to achieve best-in-class res

ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment22.1.2021 01:12:00 EETPress release

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) approved Cabenuva, the first and only complete long-acting regimen for the treatment of HIV-1 infection in adults. Cabenuva is provided as a co-pack with two injectable medicines — ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine — dosed once monthly, as an option to replace the current antiretroviral (ARV) regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per milliliter [mL]) on a stable regimen, with no history of treatment failure, and with no known or suspected resistance to either cabotegravir or rilpivirine. Prior to initiating treatment of Cabenuva, oral dosing of cabotegravir and rilpivirine should be administered for approximately one month to assess the tolerability of each therapy.1 Lynn Baxter, Head of North America, ViiV H

Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)22.1.2021 00:30:00 EETPress release

Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review its Biologics License Application (BLA) for retifanlimab, an intravenous PD-1 inhibitor, as a potential treatment for adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal (SCAC) who have progressed on, or who are intolerant of, platinum-based chemotherapy. The BLA submission is based on data from the Phase 2 POD1UM-202 trial evaluating retifanlimab in previously treated patients with locally advanced or metastatic SCAC who have progressed on, or are intolerant of, standard platinum-based chemotherapy. The trial enrolled 94 patients, including several with well-controlled human immunodeficiency virus (HIV) infection. The study, which was recently presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020, resulted in an objective response rate (ORR) of 14% for retifanlimab monotherapy as determined by inde

Wistron and Kalray Announce FURIO1200™ Storage Appliance21.1.2021 19:45:00 EETPress release

Wistron, a leader in ICT (Information and communications technology) products, and Kalray (Paris:ALKAL) (Euronext Growth Paris: ALKAL), a leading provider in new generation of processors specialized in Intelligent Data Processing from Cloud to Edge, announce the availability of FURIO1200™, a 24-Flash-Drive NVMe-oF based storage node appliance, integrating Kalray’s NVMe-oF K200™ smart storage adapter, powered by its MPPA® Coolidge™ intelligent processor, and Wistron LYMMA chassis. FURIO1200™ is a new type of hyper-fast disaggregated storage solution delivering ultra-high throughput and reliability. It is the ideal solution for Cloud Service Providers and Enterprises running applications with intensive AI and Data Analytics workloads as well as to optimize their next generation storage. Data Centers are undergoing a very important revolution due to the explosion of usages, the surge of data to be processed and the exponential growth of the number of machines to be managed to support this

NumAlim Selects Dawex and Orange Business Services for its Data and Services Exchange Platform21.1.2021 19:40:00 EETPress release

NumAlim announced an agreement with Dawex, the leader in Data Exchange technology, and Orange Business Services, a network-native digital services company, to deploy its agri-food digital exchange platform. By relying on these two leading players, NumAlim chose secure technological solutions guaranteeing the sovereignty of French food data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005722/en/ (Photo: Dawex) As early as Q1 2021, the NumAlim data and services exchange "Hub" will offer 18,000 companies in the food industry the opportunity to valorize, acquire and enrich all types of data: production, consumption, traceability, consumer opinions and research, as well as a wide range of services based on data (trend analysis, reformulation, regulatory watch…). "NumAlim is the answer to the needs for transparency, value creation and trust expressed by the food industry, consumers, and public authorities.” says Jérôme Fr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom